OrthoPediatrics announced an expansion into the U.K. market with the approval and launch of two surgical systems.
The company recently received U.K. regulatory clearance for its Pediatric Nailing Platform | FEMUR (PNP | FEMUR), which was launched in the U.S. in 2018.
Also, following its early 2020 acquisition of ApiFix technology, the company has initiated clinical use of its ApiFix deformity correction system in the U.K. The system acts as an internal brace implanted unilaterally on the concave aspect of spinal curvature, and includes a unidirectional, self-adjusting rod mechanism and motion-preserving polyaxial joints, which allow for additional post-op correction over time.
“Our continued international expansion represents our commitment to being the end-to-end provider of pediatric orthopedics solutions around the globe. Our ability to provide innovative technology to pediatric orthopedic surgeons in their home markets is something I am very proud of, and as we head into the new year, we look forward to expanding our global footprint.” - Dave Bailey, OrthoPediatrics President